Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001342 |
---|---|
Receipt number | R000001629 |
Scientific Title | Phase II study of combination therapy with Irinotecan and S-1 in patients with progressive colorectal cancer after FOLFOX regimen |
Date of disclosure of the study information | 2008/08/29 |
Last modified on | 2017/04/30 18:25:18 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/08/29 14:39:55 | ||
2 | Update | 2009/09/15 19:53:35 | Recruitment status |
|
3 | Update | 2009/09/17 09:23:27 | UMIN ID1 |
|
4 | Update | 2009/10/28 12:42:06 | UMIN ID2 |
|
5 | Update | 2009/10/30 12:22:21 | Organization Organization Organization1 |
|
6 | Update | 2009/11/20 18:29:20 | Institutions |
|
7 | Update | 2010/05/14 14:10:22 | Recruitment status Last follow-up date |
|
8 | Update | 2010/05/20 19:25:57 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
9 | Update | 2014/03/31 21:40:12 | TEL Last name of contact person Last name of contact person Address Address TEL Name of person sending information Name of person sending information Organization Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. Email1 Institutions |
|
10 | Update | 2016/02/24 19:06:08 | Acronym Acronym |
|
11 | Update | 2016/03/29 11:10:03 | Email Email1 Institutions |
|
12 | Update | 2016/09/04 18:24:46 | Name of primary person or sponsor Organization |
|
13 | Update | 2017/01/13 13:23:15 | Anticipated trial start date |
|
14 | Update | 2017/01/13 13:38:26 | Public title |
|
15 | Update | 2017/04/30 18:25:18 | Recruitment status |